Chronic Cough and Phlegm in Subjects Undergoing Comprehensive Health Examination in Japan – Survey of Chronic Obstructive Pulmonary Disease Patients Epidemiology in Japan (SCOPE-J)

Purpose The purpose of this study was to estimate the prevalence of subjects with chronic cough and phlegm and describe their characteristics including the presence or absence of airflow limitation among the general population in Japan. Subjects and Methods This was an observational cross-sectional survey targeting multiple regions of Japan. Subjects aged 40 years or above who were undergoing comprehensive health examination were recruited. The existence of chronic cough and phlegm, airflow limitation, and treatment for respiratory diseases were examined. Chronic cough and phlegm were defined as having both symptoms for at least 3 months of the year and for at least 2 consecutive years, or as receiving any treatment for chronic bronchitis at the time of recruitment. Airflow limitation was defined as forced expiratory volume in 1 s/forced vital capacity (FEV1/FVC) less than 0.7. Results In a total of 22,293 subjects, 380 subjects (1.7%) had chronic cough and phlegm. Among these 380 subjects, 21.8% received treatment for a respiratory disease, and 11.6% had airflow limitation. Compared to subjects without both chronic cough and phlegm but with airflow limitation, subjects with chronic cough and phlegm without airflow limitation were younger, more likely to be current smokers (39.6%), and had higher total scores on a chronic obstructive pulmonary disease (COPD) assessment test (CAT). Scores of CAT questions 1–4 (cough, phlegm, chest tightness, breathlessness, respectively) were higher in subjects with chronic cough and phlegm regardless of airflow limitation. Conclusion This study demonstrated that subjects identified to have chronic cough and phlegm in comprehensive health examination settings were symptomatic, while most of them did not receive any treatment for respiratory diseases and did not have airflow limitation. Screening subjects for chronic cough and phlegm in a comprehensive health examination followed by a detailed examination of screened subjects could be an effective approach for better management of chronic cough and phlegm. Smoking cessation should be included in the management, in consideration that around 40% of subjects with chronic cough and phlegm were current smokers.

[1]  M. Adachi,et al.  Asthma control and quality of life in a real-life setting: a cross-sectional study of adult asthma patients in Japan (ACQUIRE-2) , 2018, The Journal of asthma : official journal of the Association for the Care of Asthma.

[2]  S. Muro,et al.  Gastroesophageal reflux symptoms and nasal symptoms affect the severity of bronchitis symptoms in patients with chronic obstructive pulmonary disease. , 2018, Respiratory investigation.

[3]  C. Rhee,et al.  Different Pattern of Chronic Obstructive Pulmonary Disease Assessment Test Score between Chronic Bronchitis and Non-chronic Bronchitis Patients , 2018, Tuberculosis and respiratory diseases.

[4]  O. Franco,et al.  Epidemiology and impact of chronic bronchitis in chronic obstructive pulmonary disease , 2017, European Respiratory Journal.

[5]  Robert Paine,et al.  Respiratory Symptoms Items from the COPD Assessment Test Identify Ever‐Smokers with Preserved Lung Function at Higher Risk for Poor Respiratory Outcomes. An Analysis of the Subpopulations and Intermediate Outcome Measures in COPD Study Cohort , 2017, Annals of the American Thoracic Society.

[6]  Robert Paine,et al.  Clinical Significance of Symptoms in Smokers with Preserved Pulmonary Function. , 2016, The New England journal of medicine.

[7]  H. Omori,et al.  Prevalence of airflow limitation in subjects undergoing comprehensive health examination in Japan: Survey of Chronic Obstructive pulmonary disease Patients Epidemiology in Japan , 2016, International journal of chronic obstructive pulmonary disease.

[8]  A. Malarcher,et al.  Trends in Quit Attempts Among Adult Cigarette Smokers - United States, 2001-2013. , 2015, MMWR. Morbidity and mortality weekly report.

[9]  T. Harrison,et al.  Causes of chronic productive cough: An approach to management. , 2015, Respiratory medicine.

[10]  Meilan K. Han,et al.  Clinical and Radiologic Disease in Smokers With Normal Spirometry. , 2015, JAMA internal medicine.

[11]  Stephanie A. Santorico,et al.  Prediction of acute respiratory disease in current and former smokers with and without COPD. , 2014, Chest.

[12]  R. D. Dal Negro,et al.  Extent and prevalence of cognitive dysfunction in chronic obstructive pulmonary disease, chronic non-obstructive bronchitis, and in asymptomatic smokers, compared to normal reference values , 2014, International journal of chronic obstructive pulmonary disease.

[13]  A. Igarashi,et al.  Web-based survey on smoking cessation behaviors of current and former smokers in Japan , 2014, Current medical research and opinion.

[14]  A. Buist,et al.  Exacerbation-like respiratory symptoms in individuals without chronic obstructive pulmonary disease: results from a population-based study , 2014, Thorax.

[15]  E. Regan,et al.  The clinical impact of non-obstructive chronic bronchitis in current and former smokers. , 2014, Respiratory medicine.

[16]  V. Kim,et al.  Clinical issues of mucus accumulation in COPD , 2014, International journal of chronic obstructive pulmonary disease.

[17]  M. Schlesser,et al.  Chronic bronchitis in COPD patients is associated with increased risk of exacerbations: a cross‐sectional multicentre study , 2013, International journal of clinical practice.

[18]  F. Martinez,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. , 2007, American journal of respiratory and critical care medicine.

[19]  M. Dibonaventura,et al.  Patient characteristics, treatment patterns, and health outcomes among COPD phenotypes , 2012, International journal of chronic obstructive pulmonary disease.

[20]  N. Roche,et al.  Chronic bronchitis in the general population: influence of age, gender and socio-economic conditions. , 2012, Respiratory medicine.

[21]  T. Fukuda,et al.  Prevalence of airflow limitation in patients diagnosed and treated for symptoms of chronic bronchitis by general practitioners in Tochigi Prefecture, Japan. , 2011, Internal medicine.

[22]  P. Jousilahti,et al.  COPD, chronic bronchitis and capacity for day-to-day activities: Negative impact of illness on the health-related quality of life , 2010, Chronic respiratory disease.

[23]  Masakazu Nakamura,et al.  Smoking cessation patterns and predictors of quitting smoking among the Japanese general population: a 1-year follow-up study. , 2010, Addiction.

[24]  P. Jones,et al.  Development and first validation of the COPD Assessment Test , 2009, European Respiratory Journal.

[25]  Wim Timens,et al.  The pathology of chronic obstructive pulmonary disease. , 2009, Annual review of pathology.

[26]  D. Jarvis,et al.  Incidence of chronic obstructive pulmonary disease in a cohort of young adults according to the presence of chronic cough and phlegm. , 2007, American journal of respiratory and critical care medicine.

[27]  S. Braman Chronic Cough Due to Acute Bronchitis , 2006, Chest.

[28]  S. Braman Chronic Cough Due to Chronic Bronchitis , 2006, Chest.

[29]  B. Celli,et al.  Gender and COPD in patients attending a pulmonary clinic. , 2006, Chest.

[30]  B. Celli,et al.  Gender and COPD in Patients Attending a Pulmonary Clinic , 2005 .

[31]  J. Hankinson,et al.  Standardisation of spirometry , 2005, European Respiratory Journal.

[32]  T. Kuriyama,et al.  Clinical phenotypes of COPD: Results of a Japanese epidemiological survey , 2004, Respirology.